Biotechs to battle in Federal Court over ‘Access’ trade marks
Chrysiliou IP 2020-02-05 2:49 pm By Cat Fredenburgh
Please login to bookmark Close

Two biotech companies that provide molecular diagnostic products used in genetic screening will face off in Federal Court over whether one of the company’s ‘Access’ trade mark is likely to confuse consumers.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au